Semax is a heptapeptide derived from the 4–7 fragment of adrenocorticotropic hormone (ACTH), with a proline-glycine-proline (PGP) C-terminal extension that confers enhanced resistance to enzymatic degradation. Originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax has accumulated over three decades of research on cognitive enhancement, neuroprotection, and neuroplasticity — making it one of the most evidence-backed nootropic peptides available.
What Is Semax?
The parent molecule ACTH(4-7) — the sequence Met-Glu-His-Phe — was identified as the fragment responsible for the cognitive effects of full ACTH without its adrenal side-effects. Semax extends this core with a PGP tripeptide that slows proteolytic breakdown, extending the peptide's effective half-life in the nasal mucosa and CNS. The result is a peptide that can be administered intranasally and reach the brain via the olfactory epithelium pathway within minutes, bypassing the blood-brain barrier entirely.
This non-invasive delivery route — intranasal rather than subcutaneous — makes Semax particularly interesting from a practical research standpoint. No reconstitution calculator is required for intranasal Semax solutions, though researchers using reconstituted Semax for subcutaneous work should use the BAC water calculator to determine accurate dilution volumes.
Key Research Applications
BDNF Upregulation and Neuroplasticity
The most consistently replicated finding in Semax research is its ability to upregulate Brain-Derived Neurotrophic Factor (BDNF) in the hippocampus and prefrontal cortex. BDNF is the primary molecular driver of long-term potentiation — the synaptic strengthening mechanism underlying memory consolidation and skill acquisition. Studies in rodent models have shown BDNF increases of 70–140% following acute Semax administration, with effects sustained for up to 24 hours post-dose. Elevated BDNF also promotes dendritic arborisation, increasing the physical connectivity density of cortical neurons.
Working Memory and Executive Function
Multiple studies using Morris water maze and radial arm maze paradigms have demonstrated Semax-mediated improvements in spatial memory, working memory, and reference memory in animal models. The mechanism appears to involve both BDNF-dependent synaptic changes and direct modulation of dopaminergic and serotonergic tone in the prefrontal cortex — regions critical for executive function, sustained attention, and cognitive flexibility. Human studies conducted in Russia, particularly in stroke and cognitive impairment populations, have reported significant improvements in attention and memory scores.
Neuroprotection
Semax has been investigated as a neuroprotective agent in models of ischaemic stroke, oxidative stress, and excitotoxicity. It appears to attenuate glutamate-induced neuronal death by modulating NMDA receptor sensitivity and reducing reactive oxygen species production. This anti-excitotoxic profile is complementary to its pro-neuroplastic BDNF effects — simultaneously protecting existing neurons while promoting growth of new synaptic connections.
Mood and Anxiety Modulation
At higher dose ranges, Semax demonstrates anxiolytic properties mediated through serotonin system upregulation. It increases expression of serotonin transporter (SERT) and modulates 5-HT2A receptor density in limbic structures. This distinguishes it from purely stimulatory nootropics: Semax appears to improve cognitive performance while reducing the anxiety and cortisol elevation that often accompanies high cognitive demand. Researchers studying stress resilience often pair Semax with Selank — which operates via distinct GABA and enkephalin pathways — for a comprehensive dual-peptide cognitive-anxiolytic protocol.
Dosage Protocol
Standard research dosage: 300–600 mcg per day intranasally, typically split across 2–3 administrations
Higher cognitive load protocols: Some studies have used up to 900 mcg/day for short-duration intensive cognitive research
Cycle length: Most protocols run 2–4 weeks with a comparable off period to prevent receptor downregulation
Administration: Intranasal drops or spray; direct absorption through the olfactory epithelium provides rapid CNS access. Semax can also be administered subcutaneously at equivalent doses — use the BAC water calculator for reconstitution volume planning.
Storage
Semax solution should be refrigerated at 2–8°C and protected from light. Lyophilised Semax powder should be stored at -20°C and reconstituted just before use. Given the peptide's sensitivity to oxidation, minimise repeated freeze-thaw cycles by aliquoting into single-use fractions.
Semax and Selank: The Cognitive Stack
Semax and Selank are frequently co-researched as a complementary nootropic stack. Semax primarily drives BDNF-mediated cognitive enhancement with mild stimulatory properties; Selank provides anxiolytic and GABAergic balance. Together they represent both sides of the cognitive performance equation — enhancement and stress resilience — without the dependency potential of classical anxiolytics or stimulants.
Where to Buy Semax in India
Peptide Central stocks Semax at 99% purity, HPLC-verified with COA included on every order. Available with pan-India COD delivery. We supply both lyophilised powder and pre-mixed intranasal solution formats — contact us via WhatsApp to confirm current stock and formulation options.
99% HPLC-verified purity, COA included, pan-India COD delivery. Message us on WhatsApp for pricing and availability.
Order on WhatsApp